Labcorp Launches H5 Bird Flu Test
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Emerging & Zoonotic Diseases, Point-of-Care |
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 5, 2024 | Mass Spectrometry |
A new mass spectrometry technique quickly and non-invasively assesses paracetamol levels from a single drop of saliva.
Read MorePosted by Andy Lundin | Nov 29, 2024 | Cancer, Miscellaneous, Point-of-Care |
The Center for Innovation and Translation of POC Technologies for Equitable Cancer Care showcased POC innovations for cancer detection.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Sexually Transmitted Diseases |
NOWDiagnostics has launched the First To Know Syphilis Test, an FDA-authorized over-the-counter syphilis test in the U.S.
Read More